-
The complete genomic sequences of mosquito-borne flavivirus were downloaded from the GenBank database and aligned using the Clustal W program (Table 1). A stretch of nucleotides conserved in the strains was identified and the primers were designed using the Primers Express software. The primer sequences and characteristics are shown in Table 2.
Sequence of oligonucleotide*,† Region XF-F1 (8916−8938) XF-F2 (8964−8985) XF-R (9153−9178) Primer AACATGATGGGVAARMGWGARAA AARGGMAGYMGNGCHATHTGGT GTRTCCCANCCDGCDGTRTCATCNGC Nakayama AACATGATGGGAAAAAGAGAGAA AAGGGAAGCAGGGCCATTTGGT GCTGATGATACCGCCGGGTGGGACAC SA(A) - - - - - - - - - - - A- - AA-A- - G- - - - A- - A- - CA- G- - C- - T- - - - - - T- - - - - T- - C- - C- - G- - - - - C- - Beijing-1 - - - - - - - - - - - A- - AA- A- - A- - - - A- - A- - CA- G- - C- - T- - - - - - T- - - - - T- - C- - T- - G- - - - - C- - GP78 - - - - - - - - - - - A- - AA- A- - G- - - - A- - A- - CA- G- - C- - C- - - - - - T- - - - - C- - C- - C- - G- - - - - C- - HVI - - - - - - - - - - - A- - AA- A- - G- - - - A- - A- - CA- G- - C- - T- - - - - - T- - - - - T- - C- - C- - G- - - - - C- - JaGAr01 - - - - - - - - - - - A- - AA- A- - G- - - - A- - A- - CA- G- - C- - T- - - - - - T- - - - - T- - C- - C- - G- - - - - C- - JaOArS982 - - - - - - - - - - - A- - AA- A- - G- - - - A- - A- - CA- G- - C- - T- - - - - - T- - - - - C- - C- - C- - A- - - - - C- - K94P05 - - - - - - - - - - - A- - AA- A- - G- - - - A- - A- - CA- G- - C- - T- - - - - - C- - - - - C- - C- - C- - G- - - - - C- - SA-14 - - - - - - - - - - - A- - AA- A- - G- - - - A- - A- - CA- G- - C- - T- - - - - - T- - - - - T- - C- - C- - G- - - - - C- - HawO3663 - - - - - - - - - - - A- - GA- A- - G- - - - A- - A- - TC- C- - A- - A- - - - - - A- - - - - C- - A- - C- - A- - - - - C- - 71/02GZ - - - - - - - - - - - A- - GA- A- - G- - - - A- - A- - TC- C- - A- - A- - - - - - A- - - - - C- - A- - C- - A- - - - - C- - Nauru Island - - - - - - - - - - - A- - GA- A- - G- - - - A- - A- - TC- C- - A- - A- - - - - - A- - - - - C- - A- - C- - A- - - - - C- - 16681 - - - - - - - - - - - A- - AA- A- - G- - - - A- - C- - CA- A- - C- - A- - - - - - C- - - - - C- - C- - A- - A- - - - - C- - New Guinea C - - - - - - - - - - - A- - AA- A- - G- - - - A- - C- - CA- A- - C- - A- - - - - - C- - - - - C- - C- - A- - A- - - - - C- - PUO-218 - - - - - - - - - - - A- - AA- A- - G- - - - A- - C- - CA- A- - C- - A- - - - - - C- - - - - C- - C- - A- - A- - - - - C- - H87 - - - - - - - - - - - C- - GA- A- - G- - - - A- - C- - TA- G- - T- - A- - - - - - T- - - - - C- - A- - C- - T- - - - - C- - 80-2 - - - - - - - - - - - C- - GA- A- - G- - - - A- - C- - TA- G- - T- - A- - - - - - T- - - - - C- - A- - C- - T- - - - - C- - P4 - - - - - - - - - - - A- - AC- T- - G- - - - G- - A- - CC- A- - A- - C- - - - - - T- - - - - C- - A- - A- - C- - - - - C- - P75-215 - - - - - - - - - - - A- - AC- T- - G- - - - A- - A- - CC- G- - A- - T- - - - - - T- - - - - C- - A- - A- - T- - - - - C- - 11070 - - - - - - - - - - - A- - AC- T- - G- - - - G- - A- - CC- A- - A- - C- - - - - - T- - - - - C- - A- - A- - C- - - - - C- - serum - - - - - - - - - - - A- - GA- A- - G- - - - G- - A- - CA- A- - C- - T- - - - - - T- - - - - C- - A- - T- - C- - - - - C- - FtC-3699 - - - - - - - - - - - A- - GA- A- - G- - - - G- - A- - CA- A- - C- - T- - - - - - T- - - - - C- - A- - T- - C- - - - - C- - 385-99 - - - - - - - - - - - A- - GA- A- - G- - - - G- - A- - CA- A- - C- - T- - - - - - T- - - - - C- - A- - T- - C- - - - - C- - ARC13-12 - - - - - - - - - - - A- - GA- A- - G- - - - G- - A- - CA- A- - C- - T- - - - - - T- - - - - C- - A- - T- - C- - - - - C- - Chin-01 - - - - - - - - - - - G- - GA- A- - A- - - - G- - A- - CA- A- - C- - A- - - - - - T- - - - - C- - A- - T- - C- - - - - C- - 33-G8 - - - - - - - - - - - A- - GA- A- - G- - - - A- - C- - CA- A- - C- - C- - - - - - T- - - - - T- - C- - A- - C- - - - - C- - HNY1999 - - - - - - - - - - - A- - GA- A- - G- - - - G- - A- - CA- A- - C- - T- - - - - - T- - - - - C- - A- - T- - C- - - - - C- - 17D vaccine - - - - - - - - - - - G- - AA- A- - G- - - - G- - A- - CC- T- - C- - A- - - - - - G- - - - - C- - C- - T- - A- - - - - C- - French viscerotropic - - - - - - - - - - - G- - AA- A- - G- - - - G- - A- - CC- T- - C- - A- - - - - - G- - - - - C- - C- - T- - A- - - - - C- - 17D vaccine - - - - - - - - - - - G- - AA- A- - G- - - - G- - A- - CC- T- - C- - A- - - - - - G- - - - - C- - C- - T- - A- - - - - C- - 17DD - - - - - - - - - - - G- - AA- A- - G- - - - G- - A- - CC- T- - C- - A- - - - - - G- - - - - C- - C- - T- - A- - - - - C- - 17D-213 - - - - - - - - - - - G- - AA- A- - G- - - - G- - A- - CC- T- - C- - A- - - - - - G- - - - - C- - C- - T- - A- - - - - C- - 85-82H - - - - - - - - - - - G- - AA- A- - G- - - - A- - A- - CC- T- - C- - C- - - - - - G- - - - - T- - C- - T- - G- - - - - C- - French viscerotropic - - - - - - - - - - - G- - AA- A- - G- - - - G- - A- - CC- T- - C- - A- - - - - - G- - - - - C- - C- - T- - A- - - - - C- - Trinidad 79A - - - - - - - - - - - G- - AA- A- - G- - - - G- - A- - CC- T- - C- - A- - - - - - G- - - - - C- - C- - T- - A- - - - - C- - French viscerotropic virus - - - - - - - - - - - G- - AA- A- - G- - - - G- - A- - CC- T- - C- - A- - - - - - G- - - - - C- - C- - T- - A- - - - - C- - * N=A+G+C+T, V=G+A+C, R=A+G, M=A+C, W=A+T, Y=C+T, H=A+T+C, D=G+A+T.
† DNA sequence were obtained from the GenBank databases. Accession numbers are as follows: Nakayama, EF571853.1; SA(A), D90195.1; Beijing-1, L48961.1; GP78, AF075723.1; HVI, AF098735.1; JaGAr01, AF069076.1; JaOArS982, M18370.1; K94P05, AF045551.2; SA-14, M55506.1; HawO3663, DQ672564.1; 71/02GZ, EF025110.1; Nauru Island, U88535.1; 16681, U87411.1; New Guinea C, AF038403.1; PUO-218, AF038402.1; H87, M93130.1; 80-2, AF317645.1; P4, AY648301.1; P75-215, EF457906.1; 11070, M14931.2; serum, AY646354.1; FtC-3699, KR868734.1; 385-99, AY842931.3; ARC13-12, KM012188.1; Chin-01, AY490240.2; 33-G8, M12294.2; HNY1999, AF202541.1; 17D vaccine, X03700.1; French viscerotropic, U21056.1; 17D vaccine, NC_002031.1; 17DD, U17066.1; 17D-213, U17067.1; 85-82H, U54798.1; French viscerotropic, U21055.1; Trinidad 79A, AF094612.1; French viscerotropic virus, U21056.1.Table 1. Sequence alignment of oligonucleotide XF-F1, XF-F2, and XF-R with 36 flavivirus NS5 gene conserved regions.
Primer Sequence (5′−3′)* Nucleotide position Annealing temperature ( ℃) Length (bp) 1st round PCR XF-F1 AACATGATGGGVAARMGWGARAA 8916−8938 52 263 XF-R GTRTCCCANCCDGCDGTRTCATCNGC 9153−9178 2nd round PCR XF-F2 AARGGMAGYMGNGCHATHTGGT 8964−8985 54 215 XF-R GTRTCCCANCCDGCDGTRTCATCNGC 9153−9178 *N=A+G+C+T, V=G+A+C, R=A+G, M=A+C, W=A+T, Y=C+T, H=A+T+C, D=G+A+T. Table 2. Nucleotide sequences and positions of primers used in the heminested RT-PCR (hnRT-PCR) assay for detection of mosquito-borne flavivirus.
-
Viral strains, including JEV, DENV-2, YFV, WNV, Sindbis virus (SINV), and chikungunya virus (CHIKV), were provided by the National Institute for Viral Disease Control and Prevention of China CDC. Viral RNA was extracted using the Rneasy MiNi Kit (QIAGEN, Germany) and used directly for complementary DNA (cDNA) synthesis using QuantiNovaTM Reverse Transcription Kit (QIAGEN, Germany) according to the manufacturer’s recommendations. Flaviviruses NS5 gene fragments were amplified from cDNA employing the oligonucleotide primers shown in Table 2. The amplicons were purified (TransGen, Beijing, China) and then each cDNA was cloned into the pEASYR-T1 Simple Cloning Vector (TransGen, Beijing, China) and transformed into E. coli Trans1-T1 cells. Plasmid DNAs were purified using the EasyPureR Plasmid MiniPrep Kit (TransGen, Beijing, China) according to the manufacturer’s instructions. The DNAs were quantified by a NanoDrop-1000 spectrophotometry (Thermo Fisher Scientific, USA). The copy numbers of the DNA were calculated based on the concentration, and 10-fold serial dilutions of this DNA from 109 to 100 copies per reaction were used as a standard in all heminested reverse transcriptase polymerase chain reactions (hnRT-PCR).
-
The analytical sensitivity of the hnRT-PCR assay was determined by quantification with external standards using serially diluted plasmids (109–100 copies/µL) containing JEV, DENV-2, WNV, and YFV. For specificity testing, we used cDNA of JEV, DENV-2, YFV, WNV, SINV, and CHIKV. We also used mosquito samples spiked with cDNA of JEV, DENV-2, YFV, and WNV, and the cDNA of mosquito samples was used as control.
-
Mosquito samples were collected at different sites in Guizhou Province between July to August 2018. The collected mosquitoes were frozen and identified quickly and then pooled by species into groups of up 50 individuals. Viral RNAs were extracted and reverse transcribed into cDNA and the hnRT-PCR was performed using designed primers shown in Table 2.
HTML
Primer Design
Viruses, Viral RNA Extraction, and Reverse Transcription
Sensitivity and Specificity of the hnRT-PCR Assay
Field-caught Mosquitoes
Citation: |